3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
7
Pain, Postoperative
5
Leiomyoma
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Ulcer
1
Supratentorial Neoplasms
1
Sleep Wake Disorders
1
Rhabdomyosarcoma, Alveolar
1
Retinoblastoma
1
Rectal Neoplasms
1
Pulmonary Atelectasis
1
Pleural Effusion, Malignant
1
Pituitary Diseases
1
Phlebitis
1
Peripheral Nervous System Diseases
1
Patient Participation
1
Pancreatic Ductal Adenocarcinoma
1
Non-functioning Pituitary Adenoma
1
Neurotoxicity Syndromes
1
Neuralgia
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Interventions
Pleurodesis
4
Cisplatin
3
Chest Tubes
3
Bevacizumab
3
Silver Nitrate
2
Povidone-Iodine
2
camrelizumab
1
Thoracoscopy
1
Thiostrepton
1
Sodium Chloride
1
Saline Solution
1
Radiation
1
One-Lung Ventilation
1
Morphine
1
Magnetic Resonance Spectroscopy
1
Lidocaine
1
Immunotherapy, Adoptive
1
Ibuprofen
1
Genes, fms
1
Fentanyl
1
Drug Therapy
1
Doxycycline
1
Anesthesia, Local
1
Anesthesia, General
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pleural Effusion, Malignant
×
Saline Solution
×
Clear all
NCT01411202
2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2
Unknown
40 enrolled